Wate, Donato C.

HRN: 05-18-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/15/2024
06/21/2024
IV
4.5gm LD Then 2.25gm Q8
Q8
Multiple Carbuncle
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: